MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Acute Myeloid Leukemia Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,888 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,888 works in the cohort · of 4,299,418page 18 of 58

Labels cover 3 of 2,888 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,888 of 2,888 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for <scp>I</scp>nternational <scp>B</scp>lood and <scp>M</scp>arrow <scp>T</scp>ransplant <scp>R</scp>esearch cohort analysis
Fotios V. Michelis, Vikas Gupta, Mei‐Jie Zhang, Hai‐Lin Wang, Mahmoud Aljurf, Ulrike Bacher +18 more
2017· article· en· Cancer· Medicine
machine prediction:candidate · noneconsensus · none
16
citations
15
citations
affno abstractunlabeled
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis
Wasithep Limvorapitak, Michael J. Barnett, Donna E. Hogge, Donna L. Forrest, Thomas J. Nevill, Sujaatha Narayanan +10 more
2018· article· en· Clinical Lymphoma Myeloma & Leukemia· Medicine
machine prediction:candidate · noneconsensus · none
15
citations
affno abstractunlabeled
Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML
Jae‐Sook Ahn, Hyeoung‐Joon Kim, Yeo‐Kyeoung Kim, Sung‐Hoon Jung, Deok‐Hwan Yang, Je‐Jung Lee +10 more
2015· article· en· Annals of Hematology· Medicine
machine prediction:candidate · noneconsensus · none
15
citations
affunlabeled
Increased CHIP Prevalence Amongst People Living with HIV
Alexander G. Bick, Konstantin Popadin, Christian W. Thorball, Md Mesbah Uddin, Markella V. Zanni, Bing Yu +13 more
2020· preprint· en· medRxiv· Medicine
machine prediction:candidate · noneconsensus · none
15
citations

How this was built: Screen · Findings · About